Previous close | 1.4800 |
Open | 0.0010 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 1.4800 - 1.4800 |
52-week range | 0.0010 - 6.5200 |
Volume | |
Avg. volume | 1,160 |
Market cap | 13.141M |
Beta (5Y monthly) | 1.20 |
PE ratio (TTM) | N/A |
EPS (TTM) | -7.6100 |
Earnings date | 11 Jun 2024 - 15 Jun 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
SANTA CLARA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, today reported third quarter financial results for the period ended September 30, 2023. Third Quarter Highlights: Reported revenue of $12.0 million in the third quarter of 2023, compared with revenue of $12.6 million in the third quarter of 2022Increased Symphion produc
Minerva Surgical, Inc. (UTRS) delivered earnings and revenue surprises of 44.44% and 3.80%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?